UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 299

Sortiert nach

Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression

The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2362-2369

2012

Link zum Volltext

Verfügbarkeit prüfen

A consensus on the diagnosis and treatment of acromegaly complications

Pituitary, 2013-09, Vol.16 (3), p.294-302

2013

Link zum Volltext

Verfügbarkeit prüfen

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

European journal of endocrinology, 2007-01, Vol.156 (1), p.75

2007

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire

European journal of endocrinology, 2008-05, Vol.158 (5), p.623

2008

Link zum Volltext

Verfügbarkeit prüfen

Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach

Pituitary, 2015-10, Vol.18 (5), p.613-620

2015

Link zum Volltext

Verfügbarkeit prüfen

The German ACROSTUDY: past and present

European journal of endocrinology, 2009-11, Vol.161 Suppl 1, p.S3

2009

Link zum Volltext

Verfügbarkeit prüfen

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study

European journal of endocrinology, 2009-07, Vol.161 (1), p.27

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR

Experimental and clinical endocrinology & diabetes, 2011-03, Vol.119 (3), p.156

2011

Link zum Volltext

Verfügbarkeit prüfen

High-Dose Leptin Activates Human Leukocytes Via Receptor Expression on Monocytes

The Journal of immunology (1950), 2001-10, Vol.167 (8), p.4593-4599

2001

Link zum Volltext

Verfügbarkeit prüfen

Postoperative Evaluation of Patients with Acromegaly: Clinical Significance and Timing of Oral Glucose Tolerance Testing and Measurement of (Free) Insulin-Like Growth Factor I, Acid-Labile Subunit, and Growth Hormone-Binding Protein Levels

The journal of clinical endocrinology and metabolism, 2005-12, Vol.90 (12), p.6480-6489

2005

Link zum Volltext

Verfügbarkeit prüfen

Detection of doping with human growth hormone

The Lancet (British edition), 1999-03, Vol.353 (9156), p.895-895

1999

Link zum Volltext

Verfügbarkeit prüfen

Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and Men

The journal of clinical endocrinology and metabolism, 2002-12, Vol.87 (12), p.5737-5745

2002

Link zum Volltext

Verfügbarkeit prüfen

Diagnosis and treatment of acromegaly complications

Journal of endocrinological investigation, 2003-12, Vol.26 (12), p.1242-1247

2003

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement

The Journal of steroid biochemistry and molecular biology, 1992-12, Vol.43 (7), p.683-692

1992

Link zum Volltext

Verfügbarkeit prüfen

Generation of Human Soluble Leptin Receptor by Proteolytic Cleavage of Membrane-Anchored Receptors

Endocrinology (Philadelphia), 2001-10, Vol.142 (10), p.4389-4393

2001

Link zum Volltext

Verfügbarkeit prüfen

Systemic Regulation of Distraction Osteogenesis: A Cascade of Biochemical Factors

Journal of bone and mineral research, 2002-07, Vol.17 (7), p.1280-1289

2002

Link zum Volltext

Verfügbarkeit prüfen

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

European journal of endocrinology, 2016-06, Vol.174 (6), p.C1

2016

Link zum Volltext

Verfügbarkeit prüfen

Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis

European journal of endocrinology, 2006-02, Vol.154 (2), p.213

2006

Link zum Volltext

Verfügbarkeit prüfen

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

Journal of the American College of Cardiology, 1998-08, Vol.32 (2), p.393-397

1998

Link zum Volltext

Verfügbarkeit prüfen

Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results

Pituitary, 2021-12, Vol.24 (6), p.943-953

2021

Link zum Volltext

Verfügbarkeit prüfen

Salivary cortisol levels throughout childhood and adolescence : relation with age, pubertal stage, and weight

Pediatric research, 1995-04, Vol.37 (4), p.502-506

1995

Link zum Volltext

Verfügbarkeit prüfen

Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men

The journal of clinical endocrinology and metabolism, 2001-07, Vol.86 (7), p.3304-3310

2001

Link zum Volltext

Verfügbarkeit prüfen

Raised leptin concentrations at high altitude associated with loss of appetite

The Lancet (British edition), 1998-10, Vol.352 (9134), p.1119-1120

1998

Link zum Volltext

Verfügbarkeit prüfen

Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD)

Clinical endocrinology (Oxford), 2009-03, Vol.70 (3), p.439-445

2009

Link zum Volltext

Verfügbarkeit prüfen

Effects of growth hormone and insulin-like growth factor I on the immune system

European journal of endocrinology, 1995-12, Vol.133 (6), p.635

1995

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 299

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(223)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(203)
Science & Technology
(198)
Life Sciences & Biomedicine
(193)
Endocrinology & Metabolism
(130)
Male
(107)
Biological And Medical Sciences
(105)
Female
(96)
Adult
(91)
Medical Sciences
(82)
Middle Aged
(59)
Endocrinology
(49)
Fundamental And Applied Biological Sciences. Psychology
(46)
Adolescent
(41)
Aged
(34)
Endocrinopathies
(34)
Vertebrates: Endocrinology
(30)
Human Growth Hormone - Therapeutic Use
(27)
Insulin-Like Growth Factor I - Metabolism
(27)
Child
(26)
Endocrinology, Diabetes And Metabolism
(26)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression

A consensus on the diagnosis and treatment of acromegaly complications

Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: safety and efficacy evaluation from the German Pegvisomant Observational Study

Evaluation of health-related quality of life in patients with Cushing's syndrome with a new questionnaire

Intraoperative indocyanine green videoangiography for identification of pituitary adenomas using a microscopic transsphenoidal approach

The German ACROSTUDY: past and present

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study

Efficacy and acceptability of lanreotide Autogel® 120 mg at different dose intervals in patients with acromegaly previously treated with octreotide LAR

High-Dose Leptin Activates Human Leukocytes Via Receptor Expression on Monocytes

Postoperative Evaluation of Patients with Acromegaly: Clinical Significance and Timing of Oral Glucose Tolerance Testing and Measurement of (Free) Insulin-Like Growth Factor I, Acid-Labile Subunit, and Growth Hormone-Binding Protein Levels

Detection of doping with human growth hormone

Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and Men

Diagnosis and treatment of acromegaly complications

Synthesis of a cortisol-biotin conjugate and evaluation as a tracer in an immunoassay for salivary cortisol measurement

Generation of Human Soluble Leptin Receptor by Proteolytic Cleavage of Membrane-Anchored Receptors

Systemic Regulation of Distraction Osteogenesis: A Cascade of Biochemical Factors

Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations

Elevated transaminases during medical treatment of acromegaly: a review of the German pegvisomant surveillance experience and a report of a patient with histologically proven chronic mild active hepatitis

Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation

Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results

Salivary cortisol levels throughout childhood and adolescence : relation with age, pubertal stage, and weight

Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men

Raised leptin concentrations at high altitude associated with loss of appetite

Use of a GH receptor antagonist (GHRA) to explore the relationship between GH and IGF-I in adults with severe GH deficiency (GHD)

Effects of growth hormone and insulin-like growth factor I on the immune system

Suchergebnisse filtern